salmonella typhi vaccine
Vaccineexperimental
Clinical trial activity
4 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2009 (NCT01033409)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Salmonella typhiImmunity, active
Salmonella typhi immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- salmonella typhi vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03067961 | N/A | Feb 27, 2017 | Bill and Melinda Gates Foundation, University of Oxford, Yale University |
| NCT02653235 | N/A | Jan 1, 2016 | University of Glasgow |
| NCT01533285 | Early Phase 1 (Phase 1) | May 1, 2012 | Janssen Pharmaceutica NV, Johnson and Johnson |
| NCT01033409 | Phase 1 | Aug 1, 2009 | Arizona State University, St. Louis University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Arizona State University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Janssen Pharmaceutica NV | For profit | 1 | 0 | 1 | 2012 |
| Johnson and Johnson | For profit | 1 | 1 | 1 | 2012 |
| St. Louis University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Glasgow | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Yale University | Academic/Hospital | 1 | 0 | 1 | 2017 |
8 organizations
Page 1 / 1